3[3]Keown PA.Therapeutic strategies for optimal use of novel immunosuppressants.Transplant Proc,1999,31:1790-1792.
4[4]Kahan BD.Renaissance of immunosuppressive therapy in the new millennium.Transplant Proc,1998,30:2493-2496.
5[5]First MR.An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ transplantation.AM J Kidney Dis,1997,29:303-317.
6[6]Pirsch JD,Miller J,Deierhoi MH,et al.A comparison of tacrolimus(FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation,FK506 Kidney Transplant Study Group.Transplantation,1997,63:977-983.
7[7]Mayer AD,Dmitrewski J,Squifflet JP,et al.Multicenter randomized trial comparing tacrolimus(FK506) and cyclosporine in the prevention of renal allograft rejection:a report of the European Tacrolimus Multicenter Renal Study Group.Transplantation,1997,64:436-443.
